Evidence map›Paper›PMID 30323273›Full record

ReviewCell death and differentiation2018

Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Michele Carbone, Ivano Amelio, El Bachir Affar, James Brugarolas, Lisa A Cannon-Albright, Lewis C Cantley, Webster K Cavenee, Zhijian Chen, Carlo M Croce, Alan D' Andrea and 18 more

Abstract readReviewConsensus Statement
In one paragraph

Review in Cell death and differentiation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Breast cancer: pathogenesis and treatments.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Opportunities for Gene and Environment Research in Cancer: An Updated Review of NCI's Extramural Grant Portfolio.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. How asbestos and other fibers cause mesothelioma.Translational lung cancer research · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Michele CarboneHawaii Cancer Center, Honolulu, HI, USA. mcarbone@cc.hawaii.edu.
Ivano AmelioMRC Toxicology Unit, Leicester, UK.
El Bachir AffarDepartment of Medicine, Maisonneuve-Rosemont Hospital Research Center, University of Montréal, Montréal, Quebec, H1T 2M4, Canada.
James BrugarolasDepartment of Internal Medicine, Hematology-Oncology Division, Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Lisa A Cannon-AlbrightGenetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Lewis C CantleyMeyer Cancer Center, Weill Cornell Medical College, 413 E. 69(th) Street, New York, NY, 10021, USA.
Webster K CaveneeLudwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, 92093, USA.
Zhijian ChenDepartment of Molecular Biology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Carlo M CroceDepartment of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Alan D' AndreaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0001-6168-6294
David GandaraThoracic Oncology, UC Davis, Sacramento, CA, 96817, USA.
Carlotta GiorgiDepartment of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
Wei JiaHawaii Cancer Center, Honolulu, HI, USA.ORCID http://orcid.org/0000-0002-3739-8994
Qing LanOccupational & Environmental Epidemiology Branch Division of Cancer Epidemiology & Genetics National Cancer Institute NIH, Bethesda, MD, USA.
Tak Wah MakThe Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, ON, M5G 2M9, Canada.
James L ManleyDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Katsuhiko MikoshibaLaboratory for Developmental Neurobiology, RIKEN Brain Science Institute, Wako, Saitama, 351-0198, Japan.
Jose N OnuchicCenter for Theoretical Biological Physics, Rice University, Houston, TX, 77005, USA.
Harvey I PassDivision of General Thoracic Surgery, Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY, USA.
Paolo PintonDepartment of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.ORCID http://orcid.org/0000-0001-7108-6508
Carol PrivesDepartment of Biological Sciences, Columbia University, New York, New York, 10027, USA.
Nathaniel RothmanOccupational & Environmental Epidemiology Branch Division of Cancer Epidemiology & Genetics National Cancer Institute NIH, Bethesda, MD, USA.
Said M SebtiDrug Discovery Department, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida, Tampa, FL, 33612, USA.ORCID http://orcid.org/0000-0001-5163-1038
James TurksonHawaii Cancer Center, Honolulu, HI, USA.
Xifeng WuThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Haining YangHawaii Cancer Center, Honolulu, HI, USA.
Herbert YuHawaii Cancer Center, Honolulu, HI, USA.
Gerry MelinoMRC Toxicology Unit, Leicester, UK. gm89@le.ac.uk.

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Pallav Pokhrel · 1996 to 2026
$56.2M
University of Texas Southwestern Medical Center SPORE in Kidney CancerP50CA196516 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Payal Kapur, Payal Kapur · 2016 to 2026
$24.7M
Regulation of RNA processing: Mechanisms and ConsequencesR35GM118136 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI James L. Manley · 2016 to 2026
$8.9M
Targeting Mutant KRAS for Cancer TherapyR35CA197731 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SEBTI, SAID M · 2016 to 2022
$6.2M
The EDRN Mesothelioma Biomarker Discovery LaboratoryU01CA214195 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PASS, HARVEY IRA, YANG, HAINING · 2016 to 2021
$3.5M
Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early DetectionR01CA198138 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI CARBONE, MICHELE · 2015 to 2019
$1.7M
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinomaR01CA175754 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BRUGAROLAS, JAMES · 2014 to 2018
$1.6M
Medical Research Council MC_U132670600Medical Research Council MC_UU_00025/2NCI NIH HHS P30 CA071789NCI NIH HHS P50 CA196516NCI NIH HHS R01 CA175754NCI NIH HHS R01 CA198138NCI NIH HHS R35 CA197731NCI NIH HHS U01 CA214195NIGMS NIH HHS R35 GM118136
6 · The paper itself

Abstract

The relative contribution of intrinsic genetic factors and extrinsic environmental ones to cancer aetiology and natural history is a lengthy and debated issue. Gene-environment interactions (G x E) arise when the combined presence of both a germline genetic variant and a known environmental factor modulates the risk of disease more than either one alone. A panel of experts discussed our current understanding of cancer aetiology, known examples of G × E interactions in cancer, and the expanded concept of G × E interactions to include somatic cancer mutations and iatrogenic environmental factors such as anti-cancer treatment. Specific genetic polymorphisms and genetic mutations increase susceptibility to certain carcinogens and may be targeted in the near future for prevention and treatment of cancer patients with novel molecularly based therapies. There was general consensus that a better understanding of the complexity and numerosity of G × E interactions, supported by adequate technological, epidemiological, modelling and statistical resources, will further promote our understanding of cancer and lead to novel preventive and therapeutic approaches.

Indexed as

Gene-Environment InteractionPrecision MedicineCarcinogenesisDNA DamageGenome-Wide Association StudyHumansNeoplasmsToll-Like ReceptorsTumor Suppressor Protein p53Toll-Like ReceptorsTumor Suppressor Protein p53

Identifiers

PMID30323273
PMCPMC6219489

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.